Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume & Demand by Type, Application & End-User The global wearable injectors market will witness a robust CAGR of 12.46%, valued at $6.17 billion in 2021, expected to appreciate and reach $17.75 billion by 2030, confirms Strategic Market Research. Wearable injectors (WIs) are delivery systems that adhere to the body and administer greater amounts of medicine (more than 2 mL) intravenously, subcutaneously, and intramuscularly. Wearable injectors treat many diseases like diabetes, cardiovascular diseases, cancer, and others. According to the WCRF (World Cancer Research Fund International), more than 18 million people were infected with different forms of cancer in 2020 at an age-standardized incidence rate of 190. The earliest syringe was invented by Blaise Pascal in 1650 as an application of Pascal’s law. In 1844, Francis Rynd invented the first hypodermic syringe. The first injector pen to administer insulin to the body was invented by Novo Nordisk in 1985. In March 2015, a delivery method was introduced for pegfilgrastim injection through an on-body wearable injector. Wearable injectors allow patients to be easily treated at home without being exposed to other diseases at the hospital. The patients can also control the dose amount and the dosage frequency while wearing the device. The device is also convenient to wear, with the drug being administered subcutaneously. Market Drivers - Low Cost of Wearable Injectors, Increasing Prevalence of Diseases, and Growth of the Biopharmaceutical Industry Wearable Injectors are inexpensive as compared to the other drug delivery systems. For example, an insulin pump costs about USD 4000, while a wearable insulin injector costs around USD 20 to USD 35. The cost-effectiveness of wearable injectors causes their demand to increase, which drives the market growth. The rising prevalence of diseases (like aortic aneurysm) among the world’s population has positively impacted the global market trends. According to a study published in Pulsus journal, 4500 people die from aortic aneurysms every year in the US, with an additional 1400 deaths due to aortic aneurysms caused by surgical errors. The growth of the biopharmaceutical industry has allowed for more wearable injectors to be developed, which induced the overall industry growth. According to a study by PhRMA (Pharmaceutical Research and Manufacturers of America), 31 biosimilars (a type of biopharmaceutical) were approved in 2020. Market Restraints - Preference for Alternative Drug Delivery Methods As most patients are unaware of how to use the wearable injectors, they prefer alternate drug delivery methods, which causes the demand for wearable injectors to decrease and hinders the market growth. Market Opportunities - Newer Applications of Wearable Injectors According to the American Lung Organisation, 500 to 1000 new cases of pulmonary arterial hypertension are reported every year. Chronic diseases such as rheumatoid arthritis, pulmonary arterial hypertension, cardiovascular disease, cancer, Type 1 diabetes, and autoimmune diseases can be treated with wearable injectors, which in turn is driving the industry. Also, Wearable injectors has some advanced features, resulting in an increase in usage among patients worldwide, which in turn is boosting the wearable injectors’ market size. Newer devices such as Dual Cartridge Injector, Sonceboz wearable injector, Auto Reconstitution Injector, reusable auto-injector, Amgen wearable injector, and Subcutaneous Drug Delivery Devices are being used in mAb-based biotherapy, wearable insulin pumps at-home drug delivery, and in infusion therapy. The advent of some innovative injector devices such as QuickDose wearable injector from CCBio, Sorrel Medical’s wearable drug delivery device platform, E3D’s on-body injector, Ypsodose by Ypsomed, and SmartDose injector with Freedom60 syringe infusion are rising the demand for wearable injectors. The new products developed will have a significant impact on the large volume wearable injectors market, ultra-large volume wearable injectors market, wearable drug delivery devices market, wearable defibrillator market, and the wearable tech industry. Market Analysis Of Different Segments Covered in the Report Based on Type On-body Off-body Based on Technology Spring-based Motor-driven Rotary Pump Expanding Battery Others Based on Application Oncology Infectious Diseases Cardiovascular Diseases Autoimmune Diseases Others Based on End-Use Hospitals Clinics Home Care Others Regional Coverage Analysis North America United States of America Canada Rest of North America Europe United Kingdom Germany France Rest of Europe Asia-Pacific Japan China Rest of Asia-Pacific LAMEA Brazil Mexico South Africa Rest of LAMEA Segments Analysis & Insights With a market share of 85%, the on-body segment is expected to continue its dominance throughout the forecasted period. The on-body wearable injectors allow the user to easily control the dosage amount, and they’re also water-resistant and easy to use at home. With a market share of 36.3% in 2020, the spring-based segment has the largest market size by technology due to the increased demand for adhesive patches, which are user-friendly and allow patients to deliver the medicine subcutaneously, quickly, and accurately by pushing one or more buttons on the device. According to a study, the Subcuject spring-based wearable injector accurately delivers a 3 mL, 1 cP viscous dose within 4 minutes. According to the Canadian Cancer Society, around 7% of Canadian men will develop lung and bronchus cancer, and around 5% will die from it. The oncology segment had the largest market share in 2020 by application with a 29.9% share because of the increased frequency of cancer and the increasing trend toward patients’ self-administration of medicine. The home care sector significantly dominated the market in 2020, accounting for 42% of the total industry share, and is predicted to continue dominating throughout the forecast period. This is attributable to a growing desire for self-administration of medications, the low cost of wearable injectors, and a growing demand to reduce healthcare expenses. According to a study, wearable injectors cost around USD 20 to USD 30, while infusion therapy costs from USD 200 to USD 1000 or more. The high costs of hospital therapy drive the growth of the home care segment. North America is the largest market by region, accounting for 41.5% of the total industry share because of the increased frequency of chronic and lifestyle-related disorders and the availability of advanced healthcare infrastructure. According to the CDC, around 37 million Americans have diabetes, and around 90 to 95% of them have type 2 diabetes. However, with a CAGR of 12.4%, Asia Pacific is expected to be the fastest-growing wearable injectors market throughout the projection period. This can be linked to rising geriatric patients, particularly in Japan. According to data published by the World Bank, 35 million or 28% of the Japanese population are 65 years and older. The increase in chronic illnesses like diabetes also helps to drive the growth of the industry. According to the International Diabetes Federation, 141 million or 10.6% of the Chinese population have diabetes, which costs the government USD 109 billion. Wearable Injectors Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 Market size value in 2021 USD 6.17 Billion Revenue forecast in 2030 USD 17.76 billion Growth rate CAGR of approximately 12.46% Base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2020 - 2030) Segmentation By Type, By Technology, By Application, By End-use, and By Region By Type On-body, Off-body By Technology Spring-based, Motor-driven, Rotary Pump, Expanding Battery, Others By Application Oncology, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Others By End-Use Hospitals, Clinics, Home Care, Others By Region Asia Pacific, North America, Europe, LAMEA Country Scope United States of America, Japan, United Kingdom, Germany, France, Canada, China, Brazil, Mexico, South Africa, etc. Company Usability Profiles Becton, Dickinson and Company, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Unilife Corporation, SteadyMed Therapeutics, Inc., Amgen, Inc., Insulet Corporation, Enable Injections, West Pharmaceutical Services, Inc., CeQur SA, Ypsomed Global Wearable Injectors Market Competitive Landscape Analysis Major companies are concentrating on growth tactics such as new product releases, collaborations, partnerships, operational expansion, mergers and acquisitions, and patient awareness campaigns. Becton, Dickinson, and Company Johnson & Johnson Services, Inc. F. Hoffmann-La Roche Ltd. Unilife Corporation SteadyMed Therapeutics, Inc. Amgen, Inc. Insulet Corporation Enable Injections West Pharmaceutical Services, Inc. CeQur SA Ypsomed Recent Developments In April 2021, Medtronic plc announced the launch of the Medtronic Extended infusion set in certain European countries, making it the first and only infusion set that may be worn for up to 7 days. This advancement increases the amount of time an infusion set can be worn, allowing patients to safely continue on insulin pump therapy with fewer pauses and insertions while adding convenience and comfort to their diabetes management routine. In April 2021, Amgen announced the effective acquisition of Five Prime Therapeutics, a clinical-stage biotechnology firm focusing on developing immuno-oncology and targeted cancer medicines. Amgen believes that by acquiring Five Prime, it will be able to benefit patients who have stomach cancer by leveraging bemarituzumab, Five Prime’s first-in-class program for gastric cancer. In March 2021, Aptar and Noble International announced their partnership with dne pharma, a pioneer in addiction medication in Northern Europe. The collaboration intends to reduce the life-threatening consequences of opioid overdose in Europe as quickly as possible by utilizing Ventizolve, Aptar, and Noble’s unique Unidose Liquid System. In February 2021, United Therapeutics Corporation announced that it had begun commercial sales of the revolutionary Remunity Pump for Remodulin for patients with pulmonary arterial hypertension (PAH). United Therapeutics Corporation believes that the release of the Remunity Pump will improve the lives of PAH patients through continuous delivery of Remodulin. In January 2021, Insulet Corporation announced the launch of the Omnipod DASH Insulin Management System (Omnipod DASH System) in Canada. With the Omnipod DASH System’s elegant, touchscreen Personal Diabetes Manager (PDM) and the existing benefits of Pod treatment, Canadian users will have even more freedom, flexibility, and discretion to simplify their diabetes care. Various Leading Wearable Injector Devices that Key Market Leaders Develop Name of the Product Function Key Player Subcuject wearable bolus injector Single-use injection using osmosis Subcuject Omnipod Insulin Management System Used for Insulin infusion Omnipod BD Evolve on-body injector Programmable and flexible drug delivery system capable of continuous, episodic, or delayed dose delivery across a range of volumes for up to three days. Becton, Dickinson and Company Philips-Medisize’s OBI Noise-free infusion of drugs Philips-Medisize enFuse On-Body Infusor self-administration of high-volume drugs Enable Injections Frequently Asked Question About This Report What is the wearable injectors market growth? The global wearable injectors market is expected to grow at a compound annual growth rate (CAGR) of 12.46% from 2021 to 2030 to reach USD $17.75 Billion by 2030. How big is the wearable injectors market? The global wearable injectors market size was $6.17 Billion in 2021 and is predicted to reach $17.75 Billion by 2030 with a CAGR of 12.46%. Which segment leads the market by type? The on-body segment leads the by type. Which are the major industry players in the global market? The key competitors in the market are Becton, Dickinson and Company, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Unilife Corporation, SteadyMed Therapeutics, Inc., Amgen, Inc., Insulet Corporation, Enable Injections, West Pharmaceutical Services, Inc., CeQur SA, and Ypsomed. What are the factors driving the market? Low cost of wearable injectors, increasing prevalence of diseases, and Growth of the Biopharmaceutical Industry are driving the market growth. Sources https://www.wcrf.org/cancer-trends/global-cancer-data-by-country/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076160/ https://phrma.org/-/media/Project/PhRMA/PhRMA-Org/PhRMA-Org/PDF/P-R/PhRMA_2021-Special-301_Review_Comment-1.pdf https://www.lung.org/lung-health-diseases/lung-disease-lookup/pulmonary-arterial-hypertension/learn-about-pulmonary-arterial-hypertension https://www.ondrugdelivery.com/wp-content/uploads/2020/09/Wearable-Injectors-ONdrugDelivery-Issue-111-Sep-2020.pdf 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Wearable Injections Market 4.2.1 market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 market, by region, 2021-2030 (USD Million) 4.4 By Type Business Analysis 4.4.1 market, By Type, 2021-2030 (USD Million) 4.5 By End-User Business Analysis 4.5.1 market, By End-User, 2021-2030 (USD Million) 4.6 Application Business Analysis 4.6.1 market, By Application, 2021-2030 (USD Million) 4.6 Technology Business Analysis 4.6.1 market, By Technology, 2021-2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9 Business Environment Analysis Tool 4.9.1 market PEST analysis 4.9.2 market Porter’s analysis 4.10 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Technology Analysis 5.11.1. Trends in Technology (2014-2020) 5.11.2. Trends in Technology (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Type Type 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Market: By Type Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. On-body 7.3.1. On-body market, 2021-2030 (USD Million) 7.4. Off-body 7.4.1. Off-body market, 2021-2030 (USD Million) 8. Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Hospitals 8.3.1. Hospitals market, 2021-2030 (USD Million) 8.4. Clinics 8.4.1. Clinics market, 2021-2030 (USD Million) 8.5. Home Care 8.5.1. Home Care market, 2021-2030 (USD Million) 8.5. Others 8.5.1. Others market, 2021-2030 (USD Million) 9. Market: By Application Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Oncology 9.3.1. Oncology market, 2021-2030 (USD Million) 9.4. Infectious Diseases 9.4.1. Infectious Diseases market, 2021-2030 (USD Million) 9.5. Cardiovascular Diseases 9.5.1. Cardiovascular Diseases market, 2021-2030 (USD Million) 9.6. Autoimmune Diseases 9.6.1. Autoimmune Diseases market, 2021-2030 (USD Million) 9.7. Others 9.7.1. Others market, 2021-2030 (USD Million) 10. Market: By Technology Segment Analysis 10.1. Introduction 10.2. Sales Volume & Revenue Analysis (2021-2030) 10.3. Spring-based 10.3.1. Spring-based market, 2021-2030 (USD Million) 10.4. Motor-driven 10.4.1. Motor-driven market, 2021-2030 (USD Million) 10.4. Rotary Pump 10.4.1. Rotary Pump market, 2021-2030 (USD Million) 10.4. Expanding Battery 10.4.1. Expanding Battery market, 2021-2030 (USD Million) 10.4. Others 10.4.1. Others market, 2021-2030 (USD Million) 11. Market: Regional Outlook 11.1 North America 11.1.1. North American market, by By Type, 2021-2030 (USD Million) 11.1.2. North America market, by By End-User, 2021-2030 (USD Million) 11.1.3. North America market, by Technology, 2021-2030 (USD Million) 11.1.4. North America market, by Country, 2021-2030 (USD Million) 11.1.4.1. U.S. 11.1.4.1.1. U.S. market, by By Type, 2021-2030 (USD Million) 11.1.4.1.2. U.S. market, by By End-User, 2021-2030 (USD Million) 11.1.4.1.3. U.S. market, by Technology, 2021-2030 (USD Million) 11.1.4.2. Canada 11.1.4.2.1. Canada market, by By Type, 2021-2030 (USD Million) 11.1.4.2.2. Canada market, by By End-User, 2021-2030 (USD Million) 11.1.4.2.3. Canada market, by Technology, 2021-2030 (USD Million) 11.2. Europe 11.2.1. Europe market, by By Type, 2021-2030 (USD Million) 11.2.2. Europe market, by By End-User, 2021-2030 (USD Million) 11.2.3. Europe market, by Technology, 2021-2030 (USD Million) 11.2.4. Europe market, by country, 2021-2030 (USD Million) 11.2.4.1 U.K. 11.2.4.1.1. U.K. market, by By Type, 2021-2030 (USD Million) 11.2.4.1.2. U.K. market, by By End-User, 2021-2030 (USD Million) 11.2.4.1.3. U.K. market, by Technology, 2021-2030 (USD Million) 11.2.4.2. Germany 11.2.4.2.1. Germany market, by By Type, 2021-2030 (USD Million) 11.2.4.2.2. Germany market, by By End-User, 2021-2030 (USD Million) 11.2.4.2.3. Germany market, by Technology, 2021-2030 (USD Million) 11.2.4.3. France 11.2.4.3.1. France market, by By Type, 2021-2030 (USD Million) 11.2.4.3.2. France market, by By End-User, 2021-2030 (USD Million) 11.2.4.3.3. France market, by Technology, 2021-2030 (USD Million) 11.2.4.4. Rest of Europe 11.2.4.4.1. Rest of Europe market, by By Type, 2021-2030 (USD Million) 11.2.4.4.2. Rest of Europe market, by By End-User, 2021-2030 (USD Million) 11.2.4.4.3. Rest of Europe market, by Technology, 2021-2030 (USD Million) 11.3. Asia Pacific 11.3.1. Asia Pacific market, by By Type, 2021-2030 (USD Million) 11.3.2. Asia Pacific market, by By End-User, 2021-2030 (USD Million) 11.3.3. Asia Pacific market, by Technology, 2021-2030 (USD Million) 11.3.4. Asia Pacific market, by country, 2021-2030 (USD Million) 11.3.4.1. China 11.3.4.1.1. China market, by By Type, 2021-2030 (USD Million) 11.3.4.1.2. China market, by By End-User, 2021-2030 (USD Million) 11.3.4.1.3. China market, by Technology, 2021-2030 (USD Million) 11.3.4.2. India 11.3.4.2.1. India market, by By Type, 2021-2030 (USD Million) 11.3.4.2.2. India market, by By End-User, 2021-2030 (USD Million) 11.3.4.2.3. India market, by Technology, 2021-2030 (USD Million) 11.3.4.3. Japan 11.3.4.3.1. Japan market, by By Type, 2021-2030 (USD Million) 11.3.4.3.2. Japan market, by By End-User, 2021-2030 (USD Million) 11.3.4.3.3. Japan market, by Technology, 2021-2030 (USD Million) 11.3.4.4. South Korea 11.3.4.4.1. South Korea market, by By Type, 2021-2030 (USD Million) 11.3.4.4.2. South Korea market, by By End-User, 2021-2030 (USD Million) 11.3.4.4.3. South Korea market, by Technology, 2021-2030 (USD Million) 11.3.4.5. Rest of ASIA PACIFIC 11.3.4.5.1. Rest of ASIA PACIFIC market, by By Type, 2021-2030 (USD Million) 11.3.4.5.2. Rest of ASIA PACIFIC market, by By End-User, 2021-2030 (USD Million) 11.3.4.5.3. Rest of ASIA PACIFIC market, by Technology, 2021-2030 (USD Million) 11.4. Latin America 11.4.1. Latin America market, by By Type, 2021-2030 (USD Million) 11.4.2. Latin America market, by By End-User, 2021-2030 (USD Million) 11.4.3. Latin America market, by Technology, 2021-2030 (USD Million) 11.4.4. Latin America market, by country, 2021-2030 (USD Million) 11.4.4.1. Brazil 11.4.4.1.1. Brazil market, by By Type, 2021-2030 (USD Million) 11.4.4.1.2. Brazil market, by By End-User, 2021-2030 (USD Million) 11.4.4.1.3. Brazil market, by Technology, 2021-2030 (USD Million) 11.4.4.2. Mexico 11.4.4.2.1. Mexico market, by By Type, 2021-2030 (USD Million) 11.4.4.2.2. Mexico market, by By End-User, 2021-2030 (USD Million) 11.4.4.2.3. Mexico market, by Technology, 2021-2030 (USD Million) 11.4.4.3. Rest of the Latin America 11.4.4.3.1. Rest of the Latin America market, by By Type, 2021-2030 (USD Million) 11.4.4.3.2. Rest of the Latin America market, by By End-User, 2021-2030 (USD Million) 11.4.4.3.3. Rest of the Latin America market, by Technology, 2021-2030 (USD Million) 11.5. MEA 11.5.1. MEA market, by By Type, 2021-2030 (USD Million) 11.5.2. MEA market, by By End-User, 2021-2030 (USD Million) 11.5.3. MEA market, by Technology, 2021-2030 (USD Million) 11.5.4. MEA market, by Region, 2021-2030 (USD Million) 12. Competitive Landscape 12.1 Becton, Dickinson, and Company 12.1.1. Company overview 12.1.2. Financial performance 12.1.3. Type Portfolio Analysis 12.1.4. Business Strategy & Recent Development 12.2. Johnson & Johnson Services, Inc 12.2.1. Company overview 12.2.2. Financial performance 12.2.3. Type Portfolio Analysis 12.2.4. Business Strategy & Recent Development 12.3. F. Hoffmann-La Roche Ltd 12.3.1. Company overview 12.3.2. Financial performance 12.3.3. Type Portfolio Analysis 12.3.4. Business Strategy & Recent Development 12.4. Unilife Corporation 12.4.1. Company overview 12.4.2. Financial performance 12.4.3. Type Portfolio Analysis 12.4.4. Business Strategy & Recent Development 12.5. SteadyMed Therapeutics, Inc 12.5.1. Company overview 12.5.2. Financial performance 12.5.3. Type Portfolio Analysis 12.5.4. Business Strategy & Recent Development 12.6. Amgen, Inc 12.6.1. Company overview 12.6.2. Financial performance 12.6.3. Type Portfolio Analysis 12.6.4. Business Strategy & Recent Development 12.7. Insulet Corporation 12.7.1. Company overview 12.7.2. Financial performance 12.7.3. Type Portfolio Analysis 12.7.4. Business Strategy & Recent Development 12.8. Enable Injections 12.8.1. Company overview 12.8.2. Financial performance 12.8.3. Type Portfolio Analysis 12.8.4. Business Strategy & Recent Development 12.9. West Pharmaceutical Services, Inc 12.9.1. Company overview 12.9.2. Financial performance 12.9.3. Type Portfolio Analysis 12.9.4. Business Strategy & Recent Development 12.10. CeQur SA 12.10.1. Company overview 12.10.2. Financial performance 12.10.3. Type Portfolio Analysis 12.10.4. Business Strategy & Recent Development 12.11. Ypsomed 12.11.1. Company overview 12.11.2. Financial performance 12.11.3. Type Portfolio Analysis 12.11.4. Business Strategy & Recent Development List of Tables (59 Tables) TABLE 1. MARKET, By Type, 2021-2030 (USD Million) TABLE 2. MARKET FOR On-body, BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR Off-body, BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET, By End-User, 2021-2030 (USD Million) TABLE 5. MARKET FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 6. MARKET FOR Clinics, BY REGION, 2021-2030 (USD Million) TABLE 7. MARKET FOR Home Care, BY REGION, 2021-2030 (USD Million) TABLE 8. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 9. MARKET, BY TECHNOLOGY, 2021-2030 (USD Million) TABLE 10. MARKET FOR Spring-based, BY REGION, 2021-2030 (USD Million) TABLE 11. MARKET FOR Motor-driven, BY REGION, 2021-2030 (USD Million) TABLE 12. MARKET FOR Rotary Pump, BY REGION, 2021-2030 (USD Million) TABLE 13. MARKET FOR Expanding Battery, BY REGION, 2021-2030 (USD Million) TABLE 14. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 15. MARKET, BY Application, 2021-2030 (USD Million) TABLE 16. MARKET FOR Oncology, BY REGION, 2021-2030 (USD Million) TABLE 17. MARKET FOR Infectious Diseases, BY REGION, 2021-2030 (USD Million) TABLE 18. MARKET FOR Cardiovascular Diseases, BY REGION, 2021-2030 (USD Million) TABLE 19. MARKET FOR Autoimmune Diseases, BY REGION, 2021-2030 (USD Million) TABLE 20. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 21. MARKET, BY REGION, 2021-2030 (USD Million) TABLE 22. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 23. NORTH AMERICA MARKET, By Type, 2021-2030 (USD Million) TABLE 24. NORTH AMERICA MARKET, By End-User, 2021-2030 (USD Million) TABLE 25. NORTH AMERICA MARKET, BY TECHNOLOGY, 2021-2030 (USD Million) TABLE 26. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 27. EUROPE MARKET, By Type, 2021-2030 (USD Million) TABLE 28. EUROPE MARKET, By End-User, 2021-2030 (USD Million) TABLE 29. EUROPE MARKET, BY TECHNOLOGY, 2021-2030 (USD Million) TABLE 30. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 31. ASIA-PACIFIC MARKET, By Type, 2021-2030 (USD Million) TABLE 32. ASIA-PACIFIC MARKET, By End-User, 2021-2030 (USD Million) TABLE 33. ASIA-PACIFIC MARKET, BY TECHNOLOGY, 2021-2030 (USD Million) TABLE 34. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 35. LAMEA MARKET, By Type, 2021-2030 (USD Million) TABLE 36. LAMEA MARKET, By Application, 2021-2030 (USD Million) TABLE 37. LAMEA MARKET, BY TECHNOLOGY, 2021-2030 (USD Million) TABLE 38. Becton, Dickinson, and Company: COMPANY SNAPSHOT TABLE 39. Becton, Dickinson, and Company: OPERATING SEGMENTS TABLE 40. Johnson & Johnson Services, Inc: COMPANY SNAPSHOT TABLE 41. Johnson & Johnson Services, Inc: OPERATING SEGMENTS TABLE 42. F. Hoffmann-La Roche Ltd: COMPANY SNAPSHOT TABLE 43. F. Hoffmann-La Roche Ltd: OPERATING SEGMENTS TABLE 44. Unilife Corporation: COMPANY SNAPSHOT TABLE 45. Unilife Corporation: OPERATING SEGMENTS TABLE 46. SteadyMed Therapeutics, Inc: COMPANY SNAPSHOT TABLE 47. SteadyMed Therapeutics, Inc: OPERATING SEGMENTS TABLE 48. Amgen, Inc: COMPANY SNAPSHOT TABLE 49. Amgen, Inc: OPERATING SEGMENTS TABLE 50. Insulet Corporation: COMPANY SNAPSHOT TABLE 51. Insulet Corporation: OPERATING SEGMENTS TABLE 52. Enable Injections: COMPANY SNAPSHOT TABLE 53. Enable Injections: OPERATING SEGMENTS TABLE 54. West Pharmaceutical Services, Inc: COMPANY SNAPSHOT TABLE 55. West Pharmaceutical Services, Inc: OPERATING SEGMENTS TABLE 56. CeQur SA: COMPANY SNAPSHOT TABLE 57. CeQur SA: OPERATING SEGMENTS TABLE 58. Ypsomed: COMPANY SNAPSHOT TABLE 59. Ypsomed: OPERATING SEGMENTS List of Figures (24 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Type-Based Estimation Figure 6 Top 11 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Wearable Injectors, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Wearable Injectors, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By End-User, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By Technology, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Type, 2019 vs. 2025 (USD Million) Figure 14 Market Share, By Application, 2019 vs. 2025 (USD Million) Figure 15 Geographical Snapshot of the Market Figure 16 On-body to Witness Higher CAGR in Market for Type Segment during Forecast Period. Figure 17 Spring-based to Witness Higher CAGR in Market for Technology Segment during Forecast Period. Figure 18 Home Care to Witness Higher CAGR in Market for End-User Segment during Forecast Period. Figure 19 Oncology to Witness Higher CAGR in Market for Application Segment during Forecast Period. Figure 20 North America Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 21 Market: Drivers, Restraints, Opportunities, and Challenges Figure 22 North America: Market Snapshot Figure 23 Asia Pacific: Market Snapshot Figure 24 Vendor Dive: Evaluation Overview